Recurrent bladder infections after menopause are rarely about hygiene. They are about your vaginal flora. In a classic trial women were given local oestrogen, and their infections dropped from 5.9 to 0.5 per year (PMID 8350884).
That is not a small difference. That is a different body.
Something else bothers me here. Nearly every page on this says "hormone therapy helps", while the research shows it matters a great deal which kind.
Why do you get bladder infections more often after menopause?
Because your vaginal environment changes, and that environment protects your bladder. Oestrogen keeps the vaginal lining thick and rich in glycogen. Lactobacilli live on that glycogen and turn it into lactic acid, which keeps acidity high. When your oestrogen falls, that chain disappears and gut bacteria get room.
The main one is E. coli, and it comes from your own bowel.
That is the whole route: thinner lining, less glycogen, fewer lactobacilli, higher pH, more growth around the urethra, and a bladder infection from there (PMID 27451320).
In the trial from the introduction you can watch that route reverse step by step. Acidity fell from pH 5.5 to 3.8. Lactobacilli returned in 61% of the women, against 0% on placebo. And the growth of gut bacteria fell from 67% to 31%.
Since 2014 the whole picture has had a name: genitourinary syndrome of menopause. Recurrent bladder infections are formally listed in it, next to vaginal dryness and pain during sex (PMID 25160739).
That name is more useful than it sounds. It says your dry vagina and your fourth bladder infection this year are the same problem.
What looks like a bladder infection but is not?
Two things, and together they explain a fair share of the frustration. Genitourinary syndrome can cause burning, urgency and frequent urination with no bacteria involved. And the reverse: there can be bacteria in your urine while you have no symptoms at all.
Neither is a bladder infection, and both feel like one.
| Bladder infection | Genitourinary syndrome | Bacteria without symptoms | |
|---|---|---|---|
| What is going on | Bacterial infection of the bladder | Thin, dry lining from falling oestrogen | Bacteria in the urine, no infection |
| How it feels | Burning on passing urine, urgency, sometimes blood | Burning, urgency and frequency, often dryness too | No symptoms |
| Course | Starts fairly suddenly | Creeping, stays present, varies little | Persists |
| What it is not | Not something antibiotics resolve | Guidelines see no reason to treat it without symptoms |
That last column deserves explaining. Bacteria in the urine without symptoms are very common over 65. Both Dutch and international guidance advises against routinely testing for or treating it (PMID 30895288).
The reasoning is sober. Treating achieves nothing and breeds resistance.
Take two women of 58 with exactly the same burning on passing urine. In one, E. coli grows in the culture. In the other the culture is clean and the lining is thin and dry. Same complaint, and a course of antibiotics helps only one of them.
What a urine result means in your case is for your GP to judge. This is not a reason to refuse an investigation your doctor thinks is needed.
The dryness side of this story is in Vagifem for vaginal dryness.
Does hormone therapy work against this?
That depends on the form, and that distinction is missing from every page on the subject. A Cochrane review looked at both. Oestrogen in tablet form gave no drop in infections. Local vaginal oestrogen did.
For anyone already taking hormone therapy that is an important difference.
The figures: across four studies covering 2,798 women, oestrogen in tablet form came out at a relative risk of 1.08, with a confidence interval from 0.88 to 1.33 (PMID 18425910). That interval crosses 1, which means no clear effect. The two vaginal studies in the same review came out at 0.25 and 0.64, both clearly below 1.
Those two vaginal studies were small and used different products, so they could not be pooled. One was the estriol trial from the introduction. The other used an oestrogen ring and followed 108 women for 36 weeks.
By the end, roughly 45% of users there were still free of infection, against roughly 20% of controls (PMID 10329858).
Later American work covering 5,638 women saw infections fall from 3.9 to 1.8 per year (PMID 37178856). That study looked back through records with no control group, so it backs the direction, not the size.
Dutch guidance names local oestrogen as an option after menopause. What, how much and for how long is a prescribing decision for your GP, not something to fill in yourself. Worth raising, though, if you already use a tablet or patch and infections keep returning.
What can blood testing do here, and what can it not?
A bladder infection is not established in blood. That runs through your symptoms and your urine, as it should. Blood testing can do something else. It can show where you are in the transition, which helps explain why your body responds differently than it did five years ago.
That is a distinction I want to make explicit.
A menopause panel looks at hormones such as FSH and oestradiol. That is context, not a bladder test. It cannot decide whether you need local treatment. Your GP makes that call from your symptoms.
Which values shift in this phase is covered in hormone balance in menopause.
On cranberry, D-mannose and probiotics the honest answer is that the evidence is limited. Dutch GP guidance says as much itself. Two of the best-ranking pages on this topic sell exactly those products, which explains the tone there.
What do you take to your GP?
How often it happened this year, with dates if you have them. Dutch public guidance calls it frequently recurring from three times a year, so that number counts. Whether you also have symptoms between episodes, because that points elsewhere. And whether you notice vaginal dryness or pain during sex.
Bring fresh urine if you have symptoms at the time.
Make contact promptly for fever, chills, pain in your side or back, or feeling genuinely ill. That can point to a kidney infection and it does not wait.
Gut symptoms flaring in the same period are in gut symptoms in menopause, and the skin side in itchy skin in menopause. For the wider picture, navigating perimenopause is the starting point.
References
- Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;(2):CD005131. PMID 18425910.
- Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753-756. PMID 8350884.
- Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol. 1999;180(5):1072-1079. PMID 10329858.
- Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68(10):e83-e110. PMID 30895288.
- Tan-Kim J, Shah NM, Do D, Menefee SA. Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women. Am J Obstet Gynecol. 2023;229(2):143.e1-143.e9. PMID 37178856.
- Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42-50. PMID 27451320.
- Portman DJ, Gass MLS. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy. Menopause. 2014;21(10):1063-1068. PMID 25160739.
- Caretto M, Giannini A, Russo E, Simoncini T. Preventing urinary tract infections after menopause without antibiotics. Maturitas. 2017;99:43-46. PMID 28364867.
- NHG-Standaard Urineweginfecties. Available via richtlijnen.nhg.org.
- Thuisarts. I often have bladder infections (women). Available via thuisarts.nl.
Every blood test result at Lunara includes a professional assessment by a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
Author
